Molecular targeting of hepatocyte growth factor by an antagonist, NK4, in the treatment of rheumatoid arthritis

INTRODUCTION: Hepatocyte growth factor (HGF) is a potent proangiogenic molecule that induces neovascularization. The HGF antagonist, NK4, competitively antagonizes HGF binding to its receptor. In the present study, we determined the inhibitory effect of NK4 in a rheumatoid arthritis (RA) model using...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsunemi, Sachi, Iwasaki, Tsuyoshi, Kitano, Sachie, Matsumoto, Kunio, Takagi-Kimura, Misato, Kubo, Shuji, Tamaoki, Tomoko, Sano, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978668/
https://www.ncbi.nlm.nih.gov/pubmed/23876175
http://dx.doi.org/10.1186/ar4252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978668/
https://www.ncbi.nlm.nih.gov/pubmed/23876175
http://dx.doi.org/10.1186/ar4252

Ejemplares similares